CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. [electronic resource]
Producer: 20021105Description: 1215-21 p. digitalISSN:- 0002-9440
- Adenoma -- mortality
- Antigens, CD -- analysis
- Biomarkers, Tumor -- analysis
- CD24 Antigen
- Cell Nucleus -- pathology
- Cystadenoma -- pathology
- Cytoplasm -- pathology
- Endometrial Neoplasms -- pathology
- Female
- Follow-Up Studies
- Humans
- Immunohistochemistry
- Membrane Glycoproteins
- Neoplasm Invasiveness
- Neoplasm Staging
- Ovarian Neoplasms -- mortality
- Ovary -- cytology
- Predictive Value of Tests
- Prognosis
- Reference Values
- Retrospective Studies
- Survival Rate
- Time Factors
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.